As to "lose money on medicare patients" - there are two ways to calculate the "profit" on a patient. One is the "incremental profit" - how much more (or less) does the company make as a result of a medicare patient coming in for treatment. The other is the fully burdened cost which includes overhead, corporate salaries, etc. It is quite possible that the incremental profit from medicare patients is positive, but the fully burdened cost is negative. BUT, since the overhead must be paid even in the absence of medicare patients, it make sense to treat them .... and good PR to belly ache about "doing it at a loss". If it was *really* a loss on an incremental basis, I doubt the clinics would keep putting up with it.
But I agree, this is why you get a gauze and tape for your catheter and not a tegaderm.
Don't even think about trying to get a biopatch to go with that Tegaderm.
And why they start you with a 160 filter and keep you there if it's "good enough" even if a 180 or (shudder) a 200 would give you better clearance. Fresenius won't let docs prescribe anyone a 200 unless it goes before their cost control committee to make sure a cheaper filter is not "adquate" (not "best for the patient" but "adequate").